β-(1,3)-D-glucan from Pleurotus ostreatus correlates with lower plasma IL-6, IL-1β, HOMA-IR, and higher pancreatic beta cell count in High-Fat and High-Fructose Diet (HFFD) rats
https://doi.org/10.4081/hls.2023.11165
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Introduction: The increasing consumption of high-fat and high-fructose foods contributes to the increasing prevalence of global obesity. Low-grade chronic inflammation in obesity is a significant risk factor for insulin resistance and type 2 diabetes. Therefore, this study aimed to determine the effect of β-(1,3)-D-glucan from oyster mushroom (Pleurotus ostreatus) extract on rats fed with a high-fat and high-fructose diet.
Design and Methods: This experimental study was conducted on 35 male Sprague-Dawley rats aged eight weeks. The rats were divided into groups given a normal (N) diet, a high-fat and high-fructose diet (HFFD), D1 (HFFD+125 mg/kg BW β-glucan), D2 (HFFD+250 mg/kg BW β glucan), and D3 (HFFD+375 mg/kg BW β-glucan) with an intervention of 14 weeks. IL-6 and IL-1β levels were measured by the ELISA method, while HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) was calculated by the fasting insulin (ng/mL) x fasting blood glucose (mg/dL)/405 formula. Pancreatic beta-cell counts were measured by hematoxylin and eosin (H&E) staining.
Results: The results showed no differences in IL-6 and IL-1β between the treatment groups. However, there were significant differences in HOMA-IR and pancreatic beta-cell counts between groups. There were negative correlations between the dose of β-glucan and IL-6, IL-1β, and HOMA-IR levels. Also, there was a positive correlation between the dose of β-glucan and the number of pancreatic beta cells.
Conclusions: Administration of β-(1,3)-D-glucan from oyster mushroom (Pleurotus ostreatus) extract prevented hyperglycemia and insulin resistance, also reduced inflammation in rats fed with HFFD regardless of weight gain.
McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) 2013;4:52. DOI: https://doi.org/10.3389/fendo.2013.00052
Chen L, Chen R, Wang H, et al. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol 2015;2015:1–9. DOI: https://doi.org/10.1155/2015/508409
Kemenkes-RI. Hasil Utama Riskesdas 2018. Jakarta: Balitbangkes Kemenkes RI; 2018.
Pereira RM, Botezelli JD, da Cruz Rodrigues KC, et al. Fructose consumption in the development of obesity and the effects of different protocols of physical exercise on the hepatic metabolism. Nutrients 2017;9:405. DOI: https://doi.org/10.3390/nu9040405
Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, et al. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013;2013:1–11. DOI: https://doi.org/10.1155/2013/678159
Kern L, Mittenbühler MJ, Vesting AJ, et al. Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers. Cancers (Basel) 2019;11:24. DOI: https://doi.org/10.3390/cancers11010024
Ballak DB, Stienstra R, Tack CJ, et al. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine. 2015;75:280–90. DOI: https://doi.org/10.1016/j.cyto.2015.05.005
Bao P, Liu G, Wei Y. Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats. Int J Clin Exp Med 2015;8:13491–9.
Guillamón E, García-Lafuente A, Lozano M, et al. Edible mushrooms: Role in the prevention of cardiovascular diseases. Fitoterapia 2010;81:715–23. DOI: https://doi.org/10.1016/j.fitote.2010.06.005
Wasser S. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed J 2014 Sep 2;37. DOI: https://doi.org/10.4103/2319-4170.138318
Handayani D, Chen J, Meyer BJ, et al. Dietary Shiitake mushroom (Lentinus edodes) prevents fat deposition and lowers triglyceride in rats fed a high-fat diet. J Obes 2011;2011:1–8. DOI: https://doi.org/10.1155/2011/258051
Tjokrokusumo D. Jamur Tiram (Pleurotus ostreatus) untuk Meningkatkan Ketahanan Pangan dan Rehabilitasi Lingkungan. J Rekayasa Lingkung 2018;4:53–62. DOI: https://doi.org/10.29122/jrl.v4i1.1851
Golak-Siwulska I, Kałużewicz A, Spiżewski T, et al. Bioactive compounds and medicinal properties of Oyster mushrooms (Pleurotus sp.). Folia Hortic 2018;30:191–201. DOI: https://doi.org/10.2478/fhort-2018-0012
Zheng J, Shen N, Wang S, et al. Oat beta-glucan ameliorates insulin resistance in mice fed on high-fat and high-fructose diet. Food Nutr Res 2013;57:10.3402/fnr.v57i0.22754. DOI: https://doi.org/10.3402/fnr.v57i0.22754
Cheng Y, Zhang J, Luo K, et al. Oat bran β-glucan improves glucose homeostasis in mice fed on a high-fat diet. RSC Adv 2017;7:54717–25. DOI: https://doi.org/10.1039/C7RA10437E
Jedinak A, Dudhgaonkar S, Wu Q, et al. Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling. Nutr J 2011;10:52. DOI: https://doi.org/10.1186/1475-2891-10-52
Liu Y-W, Mei H-C, Su Y-W, et al. Inhibitory effects of Pleurotus tuber-regium mycelia and bioactive constituents on LPS-treated RAW 264.7 cells. J Funct Foods 2014;7:662–70. DOI: https://doi.org/10.1016/j.jff.2013.12.019
Kanagasabapathy G, Chua KH, Malek SNA, et al. AMP-activated protein kinase mediates insulin-like and lipo-mobilising effects of β-glucan-rich polysaccharides isolated from Pleurotus sajor-caju (Fr.), Singer mushroom, in 3T3-L1 cells. Food Chem 2014;145:198–204. DOI: https://doi.org/10.1016/j.foodchem.2013.08.051
Sheng Y, Zhao C, Zheng S, et al. Anti-obesity and hypolipidemic effect of water extract from Pleurotus citrinopileatus in C57BL/6J mice. Food Sci Nutr 2019;7:1295–301. DOI: https://doi.org/10.1002/fsn3.962
Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997;127:838S-841S. DOI: https://doi.org/10.1093/jn/127.5.838S
Yunita EP, Yuniar AM, Kusumastuty I, et al. The Effects of ß-glucan Extract from Oyster Mushroom (Pleurotus ostreatus) on Expression of Serum Malondialdehyde in Sprague dawley Rats Induced by HFHF Diet. J Phys Conf Ser 2020;1665:12035. DOI: https://doi.org/10.1088/1742-6596/1665/1/012035
Malafaia AB, Nassif PAN, Ribas CAPM, et al. Obesity induction with high fat sucrose in rats. ABCD Arq Bras Cir Dig (São Paulo) 2013;26:17–21. DOI: https://doi.org/10.1590/S0102-67202013000600005
Hariani ENS. The Effect of Beta-glucan from Oyster Mushroom Extract on Pancreatic Beta Cell Number in Male Sprague Dawley Rats given High-Fat High Fructose Diet (Unpublished Undergraduate Thesis). Universitas Brawijaya; 2021.
Firdaus MF. The Effect of Beta-glucan from Oyster Mushroom Extract on Fasting Blood Glucose Level in Male Sprague Dawley Rats given High-Fat High Fructose Diet (Unpublished Undergraduate Thesis). Universitas Brawijaya; 2021.
Roza NA V, Possignolo LF, Palanch AC, et al. Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female rats. Food Nutr Res 2016;60:28536. DOI: https://doi.org/10.3402/fnr.v60.28536
Zhu Y, Dong L, Huang L, et al. Effects of oat β-glucan, oat resistant starch, and the whole oat flour on insulin resistance, inflammation, and gut microbiota in high-fat-diet-induced type 2 diabetic rats. J Funct Foods 2020;69:103939. DOI: https://doi.org/10.1016/j.jff.2020.103939
Cheng HS, Ton S, Phang S, et al. Increased susceptibility of post-weaning rats on high-fat diet to metabolic syndrome. J Adv Res 2017;8:743–52. DOI: https://doi.org/10.1016/j.jare.2017.10.002
Yoon H-M, Jang K-J, Han MS, et al. Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated BV2 microglial cells. Exp Ther Med 2013;5:957–63. DOI: https://doi.org/10.3892/etm.2013.895
Jeong J-W, Lee HH, Han MH, et al. Ethanol extract of Poria cocos reduces the production of inflammatory mediators by suppressing the NF-kappaB signaling pathway in lipopolysaccharide-stimulated RAW 264.7 macrophages. BMC Complement Altern Med 2014;14:101. DOI: https://doi.org/10.1186/1472-6882-14-101
Jager J, Grémeaux T, Cormont M, et al. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007;148:241–51. DOI: https://doi.org/10.1210/en.2006-0692
Murphy EJ, Rezoagli E, Major I, et al. β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application. J Fungi 2020;6:1–36. DOI: https://doi.org/10.3390/jof6040356
Purbowati, Johan A, Rmd RAK. Pengaruh jamur tiram putih ( pleurotus ostreatus ) terhadap kadar glukosa darah , profil lipid dan kadar MDA pada tikus ( rattus norvegicus ) diabetes melitus. J Gizi Indones 2016;4:131–7. DOI: https://doi.org/10.14710/jgi.4.2.131-137
Asrafuzzaman M, Rahman MM, Mandal M, et al. Oyster mushroom functions as an anti-hyperglycaemic through phosphorylation of AMPK and increased expression of GLUT4 in type 2 diabetic model rats. J Taibah Univ Med Sci 2018;13:465–71. DOI: https://doi.org/10.1016/j.jtumed.2018.02.009
Huang H-Y, Korivi M, Chaing Y-Y, et al. Pleurotus tuber-regium polysaccharides attenuate hyperglycemia and oxidative stress in experimental diabetic rats. Evidence-Based Complement Altern Med 2012;2012:1–8. DOI: https://doi.org/10.1155/2012/856381
El Khoury D, Cuda C, Luhovyy BL, et al. Beta glucan: health benefits in obesity and metabolic syndrome. J Nutr Metab 2012;2012:1–28. DOI: https://doi.org/10.1155/2012/851362
Delzenne NM, Neyrinck AM, Cani PD. Gut microbiota and metabolic disorders: how prebiotic can work? Br J Nutr 2013;109:S81–5. DOI: https://doi.org/10.1017/S0007114512004047
Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab [Internet]. 2014;25:312–9. Available from: https://doi.org/10.1016/j.tem.2014.02.004 DOI: https://doi.org/10.1016/j.tem.2014.02.004
Shi J, Fan J, Su Q, et al. Cytokines and Abnormal Glucose and Lipid Metabolism. Front Endocrinol (Lausanne) 2019;10:703. DOI: https://doi.org/10.3389/fendo.2019.00703
Du B, Meenu M, Liu H, et al. A concise review on the molecular structure and function relationship of β-glucan. Int J Mol Sci 2019;20:4032. DOI: https://doi.org/10.3390/ijms20164032
Wang Y, Harding S V, Eck P, et al. High-molecular-weight β-glucan decreases serum cholesterol differentially based on the CYP7A1 rs3808607 polymorphism in mildly hypercholesterolemic adults. J Nutr 2015;146:720–7. DOI: https://doi.org/10.3945/jn.115.223206
Baeva E, Bleha R, Lavrova E, et al. Polysaccharides from Basidiocarps of Cultivating Mushroom Pleurotus ostreatus: Isolation and Structural Characterization. Molecules 2019;24:2740. DOI: https://doi.org/10.3390/molecules24152740
Chen SN, Nan FH, Chen S, et al. Safety assessment of mushroom β-glucan: Subchronic toxicity in rodents and mutagenicity studies. Food Chem Toxicol 2011;49:2890–8. DOI: https://doi.org/10.1016/j.fct.2011.08.007
Delaney B, Carlson T, Frazer S, et al. Evaluation of the toxicity of concentrated barley β-glucan in a 28-day feeding study in Wistar rats. Food Chem Toxicol 2003;41:477–87. DOI: https://doi.org/10.1016/S0278-6915(02)00298-3
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Downloads
Citations
